Información del producto
YKL-06-062 is a drug that can be used to treat skin cancer. It is a small molecule that works by regulating the activity of two enzymes, dephosphorylation and protein kinase C. YKL-06-062 inhibits the production of eumelanin by targeting cyclic AMP activated protein kinase (AMPK), which regulates the synthesis of melanin. By inhibiting this enzyme, YKL-06-062 prevents cells from producing melanin, thereby decreasing the risk for skin cancer. YKL-06-062 also has an impact on immunity, as it stimulates T cells to produce more cytokines, which are proteins that regulate immune responses.
Propiedades químicas
Consulta técnica sobre: 3D-XLD61716 YKL-06-062
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
